These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 23867235)

  • 21. HO-1/BVR-a system analysis in plasma from probable Alzheimer's disease and mild cognitive impairment subjects: a potential biochemical marker for the prediction of the disease.
    Di Domenico F; Barone E; Mancuso C; Perluigi M; Cocciolo A; Mecocci P; Butterfield DA; Coccia R
    J Alzheimers Dis; 2012; 32(2):277-89. PubMed ID: 22776971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal changes in peripheral oxidative markers in patients with Alzheimer's disease, with or without cardiovascular disease.
    Hatanaka H; Hirose D; Hirao K; Shimizu S; Kanetaka H; Hanyu H
    Geriatr Gerontol Int; 2017 Jun; 17(6):1035-1037. PubMed ID: 28635114
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease: A Case Control Study.
    Rozzini L; Lanfranchi F; Pilotto A; Catalani S; Gilberti ME; Paganelli M; Apostoli P; Padovani A
    J Alzheimers Dis; 2018; 61(3):907-912. PubMed ID: 29332043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vitamin E and Alzheimer's Disease].
    Shinohara M; Yamada M
    Brain Nerve; 2015 Dec; 67(12):1509-13. PubMed ID: 26618765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipids' peroxidation markers in Alzheimer's disease and vascular dementia.
    Gustaw-Rothenberg K; Kowalczuk K; Stryjecka-Zimmer M
    Geriatr Gerontol Int; 2010 Apr; 10(2):161-6. PubMed ID: 20446930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment.
    Chico L; Simoncini C; Lo Gerfo A; Rocchi A; Petrozzi L; Carlesi C; Volpi L; Tognoni G; Siciliano G; Bonuccelli U
    Free Radic Res; 2013 Aug; 47(8):569-76. PubMed ID: 23668794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia.
    Puertas MC; Martínez-Martos JM; Cobo MP; Carrera MP; Mayas MD; Ramírez-Expósito MJ
    Exp Gerontol; 2012 Aug; 47(8):625-30. PubMed ID: 22664577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
    Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
    Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic oxidative stress in older patients with mild cognitive impairment or late onset Alzheimer's disease.
    Cervellati C; Cremonini E; Bosi C; Magon S; Zurlo A; Bergamini CM; Zuliani G
    Curr Alzheimer Res; 2013 May; 10(4):365-72. PubMed ID: 22950912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer's disease or mild cognitive impairment - a meta-analysis of randomized controlled trials.
    Den H; Dong X; Chen M; Zou Z
    Aging (Albany NY); 2020 Feb; 12(4):4010-4039. PubMed ID: 32062613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of plasma selenium and lipid peroxidation end products in patients with Alzheimer's disease.
    Chmatalova Z; Vyhnalek M; Laczo J; Hort J; Pospisilova R; Pechova M; Skoumalova A
    Physiol Res; 2017 Dec; 66(6):1049-1056. PubMed ID: 28937243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease.
    Opii WO; Joshi G; Head E; Milgram NW; Muggenburg BA; Klein JB; Pierce WM; Cotman CW; Butterfield DA
    Neurobiol Aging; 2008 Jan; 29(1):51-70. PubMed ID: 17055614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of hydroperoxides and multimorbidity among older patients with mild cognitive impairment or late-onset Alzheimer's disease.
    Cervellati C; Romani A; Bosi C; Magon S; Passaro A; Bergamini CM; Zuliani G
    Aging Clin Exp Res; 2015 Dec; 27(6):799-804. PubMed ID: 25795344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythrocyte membrane fluidity in mild cognitive impairment and Alzheimer's disease patients.
    Vignini A; Alia S; Pugnaloni S; Giulietti A; Bacchetti T; Mazzanti L; Luzzi S; Fiorini R
    Exp Gerontol; 2019 Dec; 128():110754. PubMed ID: 31648010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases.
    Migliore L; Fontana I; Colognato R; Coppede F; Siciliano G; Murri L
    Neurobiol Aging; 2005 May; 26(5):587-95. PubMed ID: 15708433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SOMAscan-based proteomic measurements of plasma brain natriuretic peptide are decreased in mild cognitive impairment and in Alzheimer's dementia patients.
    Begic E; Hadzidedic S; Kulaglic A; Ramic-Brkic B; Begic Z; Causevic M
    PLoS One; 2019; 14(2):e0212261. PubMed ID: 30763368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum iron and copper status and oxidative stress in severe and mild preeclampsia.
    Serdar Z; Gür E; Develioğlu O
    Cell Biochem Funct; 2006; 24(3):209-15. PubMed ID: 15898124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative Stress Assessment in Alzheimer's Disease: A Clinic Setting Study.
    Vergallo A; Giampietri L; Baldacci F; Volpi L; Chico L; Pagni C; Giorgi FS; Ceravolo R; Tognoni G; Siciliano G; Bonuccelli U
    Am J Alzheimers Dis Other Demen; 2018 Feb; 33(1):35-41. PubMed ID: 28931301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic oxidative stress and conversion to dementia of elderly patients with mild cognitive impairment.
    Cervellati C; Romani A; Seripa D; Cremonini E; Bosi C; Magon S; Bergamini CM; Valacchi G; Pilotto A; Zuliani G
    Biomed Res Int; 2014; 2014():309507. PubMed ID: 24524075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral inflammatory biomarkers in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis.
    Su C; Zhao K; Xia H; Xu Y
    Psychogeriatrics; 2019 Jul; 19(4):300-309. PubMed ID: 30790387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.